Article

Rennee Rayburg, RPh, Discusses the Top Down Approach in Specialty Drug Management

Renee Rayburg, RPh, Manager Clinical Pharmacy, OptumInsight, states that if providers narrowly focus on the traditional top down approach in specialty drug management they may miss out on opportunities for additional cost savings.

Renee Rayburg, RPh, Manager Clinical Pharmacy, OptumInsight, states that if providers narrowly focus on the traditional top down approach in specialty drug management they may miss out on opportunities for additional cost savings.

When providers only focus on their top drivers, they fail to recognize the impact specialty drug patients can have on pushing higher costs. Rayburg says, “When you look at a rare disease and a drug that might cost you a couple hundred thousand dollars a year, it’s going to make a difference if you have one or two of those in your population of people.”

Related Videos
Firas El Chaer, MD, smiling during a video interview
Mikael Eriksson, PhD.
Roberto Salgado, MD.
Keith Ferdinand, MD, professor of medicine, Gerald S. Berenson chair in preventative cardiology, Tulane University School of Medicine
Screenshot of an interview with Shaun P. McKenzie, MD
Hans Lee, MD
Don M. Benson, MD, PhD, James Cancer Hospital
Picture of San Diego skyline with words ASH Annual Meeting 2024 and health icons overlaid on the bottom
Robin Glasco, MBA
Joshua K. Sabari, MD, NYU Langone Perlmutter Cancer Center
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo